PMID- 38433545 OWN - NLM STAT- MEDLINE DCOM- 20240305 LR - 20240313 IS - 2308-1430 (Electronic) IS - 0375-9660 (Print) IS - 0375-9660 (Linking) VI - 70 IP - 1 DP - 2024 Feb 28 TI - [Fixed ratio combinations GLP-1RA and basal insulin: literature review]. PG - 91-99 LID - 10.14341/probl13312 [doi] AB - The progressive nature of type 2 diabetes mellitus leads to the need for insulin therapy in a significant proportion of patients. Very often start of insulin therapy in type 2 diabetes mellitus (T2DM) is associated with weight gain and a significant increase of hypoglycemia's risk. However, innovative options, such as fixed ratio combinations of glucagon-like peptide 1 receptor agonists (GLP-1RA) and basal insulin, minimize weight gain and hypoglycemia risks and allow a greater proportion of patients to achieve individual glycemic control goals without compromising safety parameters. This review includes a description of the randomized clinical trials, as well as the results of real clinical practice of the use of two currently existing fixed ration combinations of GLP-1RA and basal insulin - iDegLira and iGlarLixi. FAU - Kurkin, D V AU - Kurkin DV AD - Russian University of Medicine; Volgograd State Medical University. FAU - Bakulin, D A AU - Bakulin DA AD - Russian University of Medicine. FAU - Morkovin, E I AU - Morkovin EI AD - Volgograd State Medical University. FAU - Strygin, A V AU - Strygin AV AD - Volgograd State Medical University. FAU - Gorbunova, Ju V AU - Gorbunova JV AD - Russian University of Medicine. FAU - Volotova, E V AU - Volotova EV AD - Volgograd State Medical University. FAU - Robertus, A I AU - Robertus AI AD - Russian University of Medicine. FAU - Makarenko, I E AU - Makarenko IE AD - Russian University of Medicine; CJSC <>. FAU - Saparova, V B AU - Saparova VB AD - Russian University of Medicine; CJSC <>. FAU - Drai, R V AU - Drai RV AD - CJSC <>. FAU - Petrov, V I AU - Petrov VI AD - Volgograd State Medical University. LA - rus PT - English Abstract PT - Journal Article PT - Review DEP - 20240228 PL - Russia (Federation) TA - Probl Endokrinol (Mosk) JT - Problemy endokrinologii JID - 0140673 RN - 0 (Insulin) RN - 0 (Insulin, Regular, Human) SB - IM MH - Humans MH - *Diabetes Mellitus, Type 2/drug therapy MH - Insulin/therapeutic use MH - Insulin, Regular, Human MH - *Hypoglycemia/chemically induced MH - Weight Gain PMC - PMC10926250 EDAT- 2024/03/04 06:46 MHDA- 2024/03/05 06:44 PMCR- 2024/02/28 CRDT- 2024/03/04 02:33 PHST- 2023/05/25 00:00 [received] PHST- 2023/08/10 00:00 [accepted] PHST- 2023/07/06 00:00 [revised] PHST- 2024/03/05 06:44 [medline] PHST- 2024/03/04 06:46 [pubmed] PHST- 2024/03/04 02:33 [entrez] PHST- 2024/02/28 00:00 [pmc-release] AID - 10.14341/probl13312 [doi] PST - epublish SO - Probl Endokrinol (Mosk). 2024 Feb 28;70(1):91-99. doi: 10.14341/probl13312.